We are live on
!
Find out more
Cetera Investment Advisers Portfolio holdings
AUM
$94B
1-Year Est. Return
20.14%
This Fund
S&P 500
This Quarter
Est. Return
+2.24%
1 Year Est. Return
+20.14%
3 Year Est. Return
+58.25%
5 Year Est. Return
+64.18%
10 Year Est. Return
+205.32%
AUM
$91.5B
AUM Growth
+$5.45B
(+6.3%)
Cap. Flow
+$4.11B
Cap. Flow
% of AUM
4.49%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
4,916
New
350
Increased
2,508
Reduced
1,736
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$131M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$93.3M |
| 3 |
Capital Group Dividend Value ETF
CGDV
|
+$89.4M |
| 4 |
Fidelity Total Bond ETF
FBND
|
+$83.7M |
| 5 |
Fidelity Enhanced International ETF
FENI
|
+$77.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$102M |
| 2 |
Janus Henderson Short Duration Income ETF
VNLA
|
+$47.8M |
| 3 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$38.8M |
| 4 |
iShares International Dividend Growth ETF
IGRO
|
+$28.4M |
| 5 |
FT Vest Growth-100 Buffer ETF December
QDEC
|
+$28.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.92% |
| 2 | Financials | 4.18% |
| 3 | Consumer Discretionary | 3.07% |
| 4 | Industrials | 2.77% |
| 5 | Healthcare | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
Beyond Meat
BYND
$268M
| $32.4K | ﹤0.01% |
39,572
+7,634
| +24% | +$10.6K |
|
4527
United Maritime
USEA
$25.4M
| $32.4K | ﹤0.01% |
19,041
+1,916
| +11% | +$3.27K |
|
4528
Magnachip Semiconductor
MX
$134M
| $31.5K | ﹤0.01% |
12,368
-342
| -3% | -$952 |
|
|
THM
4529
International Tower Hill Mines
THM
$699M
| $31.5K | ﹤0.01% |
16,948
| – | – |
|
4530
Surf Air Mobility
SRFM
$94.4M
| $31.4K | ﹤0.01% |
16,208
+1,747
| +12% | +$5.59K |
|
4531
Pyxis Oncology
PYXS
$243M
| $31.3K | ﹤0.01% |
27,260
-500
| -2% | -$1.76K |
|
4532
Ideal Power
IPWR
$71.1M
| $31.1K | ﹤0.01% |
10,060
-5,000
| -33% | -$22K |
|
|
SGMO
4533
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $30.8K | ﹤0.01% |
+73,300
| New | +$38.9K |
|
4534
Ovid Therapeutics
OVID
$489M
| $27.7K | ﹤0.01% |
17,001
+1
| +0% | +$2 |
|
4535
GoodRx Holdings
GDRX
$1.25B
| $27.7K | ﹤0.01% |
10,219
-298
| -3% | -$978 |
|
4536
ProKidney
PROK
$347M
| $27.5K | ﹤0.01% |
+12,288
| New | +$32.3K |
|
4537
TRX Gold Corp
TRX
$347M
| $26.1K | ﹤0.01% |
28,373
+10,000
| +54% | +$7.42K |
|
|
NNDM
4538
Nano Dimension
NNDM
$343M
| $26.1K | ﹤0.01% |
16,958
+530
| +3% | +$898 |
|
4539
Amprius Technologies Warrants
AMPX.WS
$542M
| $25.7K | ﹤0.01% |
10,000
| – | – |
|
4540
Caribou Biosciences
CRBU
$165M
| $25.1K | ﹤0.01% |
15,781
+898
| +6% | +$1.89K |
|
4541
Palisade Bio
PALI
$365M
| $24.7K | ﹤0.01% |
+10,512
| New | +$20.2K |
|
4542
Genasys
GNSS
$74.7M
| $24.7K | ﹤0.01% |
11,500
| – | – |
|
4543
CALL
Oracle
ORCL
$435B
| $24K | ﹤0.01% |
2,200
+2,000
| +1,000% | +$476K |
|
|
NXXT
4544
NextNRG Inc
NXXT
$44.8M
| $22.5K | ﹤0.01% |
+15,500
| New | +$26.7K |
|
4545
Innoviz Technologies
INVZ
$114M
| $21.9K | ﹤0.01% |
25,653
-246
| -0.9% | -$389 |
|
4546
CEMIG Preferred Shares
CIG
$5.84B
| $21.5K | ﹤0.01% |
+10,758
| New | +$22K |
|
|
CGC
4547
Canopy Growth
CGC
$402M
| $21.3K | ﹤0.01% |
18,675
-8,104
| -30% | -$10.4K |
|
|
INTZ
4548
Intrusion
INTZ
$17.3M
| $20.8K | ﹤0.01% |
18,087
+5
| +0% | +$8 |
|
4549
Actinium Pharmaceuticals
ATNM
$24.2M
| $20.8K | ﹤0.01% |
15,259
+768
| +5% | +$1.12K |
|
4550
CALL
Riot Platforms
RIOT
$7.34B
| $20.2K | ﹤0.01% |
4,000
-1,500
| -27% | -$25.7K |
|
Similar funds
Cetera Investment Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, Cetera Investment Advisers held 4,916 positions worth $91.5B, up 6.3% from $86B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Cetera Investment Advisers deployed $4.11B of net new capital in Q4 2025, opening 350 new positions and adding to 2,508 existing holdings. Its largest new stake was Bluerock Private Real Estate Fund: 3,212,160 shares worth $48.2M.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $102M trimmed.
- Cetera Investment Advisers's largest Q4 2025 buy was Bluerock Private Real Estate Fund: 3,212,160 shares worth $48.2M.
- Cetera Investment Advisers added most to iShares S&P 500 Value ETF in Q4 2025, an estimated $131M increase.
- Cetera Investment Advisers's biggest Q4 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $102M.
- Cetera Investment Advisers fully exited Invesco BulletShares 2025 High Yield Corporate Bond ETF in Q4 2025, selling an estimated $22.6M.
- Cetera Investment Advisers's ten largest holdings make up 17% of its $91.5B portfolio in Q4 2025.
- Cetera Investment Advisers opened 350 new positions and closed 231 in Q4 2025.
- Cetera Investment Advisers's portfolio value rose 6.3% quarter-over-quarter to $91.5B.
Based on Cetera Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.